Clinical Edge Journal Scan

Luminal A BC patients can skip radiotherapy after breast-conserving surgery


 

Key clinical point: The incidence rate of local recurrence was low even after omitting radiotherapy in women with luminal A breast cancer (BC) age ≥55 years who underwent breast-conserving surgery (BCS) followed by endocrine therapy.

Major finding: At 5 years, the cumulative incidence of local recurrence was low (2.3%; 95% CI 1.2%-4.1%), with 1.9% of patients (90% CI 1.1%-3.2%) reporting contralateral BC recurrences and 2.7% of patients (90% CI 1.6%-4.1%) reporting recurrences of any type.

Study details: This prospective cohort study included 500 women with T1N0 (tumor size < 2 cm and node negative) luminal A BC age ≥ 55 years who had undergone BCS followed by adjuvant endocrine therapy.

Disclosures: This study was supported by the Canadian Cancer Society and Canadian Breast Cancer Foundation. Some authors declared serving as consultants or members of data safety and monitoring boards or having ties with various sources.

Source: Whelan TJ et al for the LUMINA Study Investigators. Omitting radiotherapy after breast-conserving surgery in luminal A breast cancer. N Engl J Med. 2023;389(7):612-619 (Aug 17). doi: 10.1056/NEJMoa2302344

Recommended Reading

Meta-analysis shows association between diabetes and different BC subtypes in postmenopausal women
MDedge Hematology and Oncology
Weight control has direct and indirect impact in reducing breast cancer risk
MDedge Hematology and Oncology
Cancer rates rise among people under age 50
MDedge Hematology and Oncology
Commentary: Age and breast cancer, and cardiometabolic comorbidities, September 2023
MDedge Hematology and Oncology
Breast cancer: Hope in sight for improved tamoxifen therapy?
MDedge Hematology and Oncology
No link between most cancers and depression/anxiety: Study
MDedge Hematology and Oncology
Do AI chatbots give reliable answers on cancer? Yes and no
MDedge Hematology and Oncology
Mammography breast density reporting: What it means for clinicians
MDedge Hematology and Oncology
AI mammogram screening is equivalent to human readers
MDedge Hematology and Oncology
Exercise tied to lower mortality risk across cancer types
MDedge Hematology and Oncology